Retinal Pigment Epithelium (RPE) Differentiation | ASC
![](https://pinchforthtesting.com/wp-content/uploads/2024/04/bg23.png)
”
Human iPSC-derived retinal pigment epithelium (RPE) provides a physiologically relevant cell line model to understand basic ocular biology and ocular diseases. ASC’s optimized RPE differentiation protocol allows for the generation of high-quality RPE cells that express lineage-committed markers. In just a few weeks (16-20 weeks) you can produce the RPE cells you need to push your research to the next stage.
-
- RPE-like cells with typical cobblestone morphology and pigmentation
-
- High-quality and purity cells expressing RPE-specific markers
-
- RPE differentiated from iPSCs:
-
- Your healthy/ disease/engineered iPSCs
-
iPSC generation
from fibroblast/PBMC/ CD34+ cord blood cells
-
- Optional!
Control lines
- Optional!
-
- RPE differentiated from iPSCs:
-
Fast turnaround time: 2 months
RPE |
|
Biomarkers |
RPE65 – Standard |
MITF – Standard |
|
Z0-1 – Standard |
|
PMEL1 – Inquire |
Looking for iPSCs to genetically modify and further differentiate into RPE? We offer fully customizable
iPSC generation
from human or non-human tissue samples, and our genome editing experts can use
CRISPR or TARGATT™ to genetically alter the iPSCs
to suit your projects. If you need to expedite your experimental timeline, ASC also offers off-the-shelf
iPSC-derived RPE and Photoreceptor cells
. Contact us today to find the best solution for your research.
“